## Scabies Management in High-Risk Populations ### Clinical Context: Crusted (Norwegian) Scabies **Key Point:** This patient presents with features of **crusted (Norwegian) scabies**: diffuse distribution including face and scalp, minimal burrows (mites are too numerous to form discrete burrows), severe pruritus, and immunocompromising comorbidities (type 2 diabetes, CKD stage 3b). Crusted scabies harbors millions of mites and is highly contagious. ### Why Permethrin 5% Cream is the Most Appropriate Next Step **High-Yield:** Permethrin 5% cream is the **first-line topical agent** for scabies, including crusted scabies, per WHO, CDC, and standard dermatology guidelines (Rook's Dermatology, Fitzpatrick's Dermatology). Key points: 1. **Renal safety:** Permethrin is minimally absorbed systemically (~2%) and is rapidly metabolized by ester hydrolysis in the skin and liver. CKD stage 3b (eGFR 35 mL/min/1.73m²) does **NOT** contraindicate permethrin use. 2. **Efficacy:** Permethrin 5% is both scabicidal and ovicidal; it is the most evidence-based topical agent for scabies. 3. **Application in crusted scabies:** The entire body surface including face and scalp must be treated — this is standard practice for crusted scabies and is explicitly recommended in guidelines. 4. **Combination therapy:** In crusted scabies, permethrin is often combined with oral ivermectin for optimal cure, but permethrin remains the cornerstone topical agent and the most appropriate **next step** among the options provided. ### Why the Other Options Are Less Appropriate | Option | Issue | |--------|-------| | **Benzyl benzoate 10% (A)** | Benzyl benzoate is a second-line agent; 10% concentration is used in children; adults require 25%. It is more irritating and less preferred than permethrin | | **Sulfur 5% ointment (B)** | Sulfur is a second-line agent used when permethrin is unavailable or contraindicated; it is messier, malodorous, and less evidence-based than permethrin. While safe in CKD, it is not first-line | | **Oral ivermectin alone (D)** | Ivermectin monotherapy is **insufficient** for crusted scabies due to the extremely high mite burden; combination with topical therapy (permethrin) is required per guidelines. Additionally, the option incorrectly states "avoid topical agents due to renal impairment," which is factually wrong — permethrin and sulfur are both safe in CKD | ### Dosing Regimen for Crusted Scabies | Agent | Regimen | Notes | |-------|---------|-------| | **Permethrin 5%** | Apply to entire body including face/scalp, leave 8–14 hrs | Repeat after 1 week; combine with ivermectin in crusted scabies | | **Ivermectin (oral)** | 200 µg/kg | Day 1, Day 2, Day 15 (for crusted scabies; 2–3 doses needed) | | Sulfur 5–10% | Apply to entire body daily for 3–7 days | Second-line; used when permethrin unavailable | **Clinical Pearl:** In crusted scabies, **combination therapy (permethrin + oral ivermectin)** is ideal per Fitzpatrick's and Rook's. However, among the options given, **permethrin 5% applied to the entire body including face and scalp** is the most appropriate single next step, as it is the first-line topical agent and is safe in CKD. Option D (ivermectin alone) is inadequate as monotherapy and contains a factually incorrect contraindication statement regarding topical agents in renal impairment. ### Post-Treatment Monitoring - Pruritus may persist for 2–4 weeks post-treatment; this does not indicate treatment failure. - If new burrows or lesions appear after 2 weeks, repeat the permethrin course. - Household contacts must be treated simultaneously. - Fomite decontamination (washing at ≥60°C or sealing in bags for 72 hours) is essential. *Reference: Fitzpatrick's Dermatology, 9th ed.; Rook's Textbook of Dermatology, 9th ed.; WHO Model Formulary.* 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.